The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy-Reference-Cited by-同舟云学术

The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy

Published:2020-04-01 Issue:4 Volume:36 Page:324-348
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Dubé Karine¹²,Eskaf Shadi³,Evans David⁴,Sauceda John⁵,Saberi Parya⁵,Brown Brandon⁶,Averitt Dawn²⁷,Martel Krista²⁷,Meija Maria⁸,Campbell Danielle⁴,Barr Liz⁹,Kanazawa John¹,Perry Kelly¹,Patel Hursch¹,Luter Stuart¹,Poteat Tonia²¹⁰,Auerbach Judith D.²⁷¹¹,Wohl David A.¹²

Affiliation:

1. Public Health Leadership Program (PHLP), UNC Gillings School of Global Public Health, Chapel Hill, North Carolina.

2. Women's Research Initiative on HIV/AIDS (WRI), Chapel Hill, North Carolina.

3. Environmental Finance Center, UNC School of Government, Chapel Hill, North Carolina.

4. Delaney AIDS Research Enterprise (DARE) Community Advisory Board, Los Angeles, California.

5. Division of Prevention Sciences, Center for AIDS Prevention Studies (CAPS), University of California, San Francisco, San Francisco, California.

6. Department of Social Medicine, Population and Public Health, Center for Healthy Communities, University of California, Riverside School of Medicine, Riverside, California.

7. The Well Project, Norwich, Vermont.

8. The Well Project Community Advisory Board, Tamarac, Florida.

9. AIDS Clinical Trials Group (ACTG) Community Scientific Subcommittee Representative, Baltimore, Maryland.

10. UNC Department of Social Medicine, School of Medicine, Chapel Hill, North Carolina.

11. School of Medicine, University of California, San Francisco, San Francisco, California.

12. Institute of Global Health and Infectious Diseases (IGHID), University of North Carolina, Chapel Hill, North Carolina.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/aid.2019.0175

Reference34 articles.

1. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

2. The end of AIDS: HIV infection as a chronic disease

3. The Challenge of Finding a Cure for HIV Infection

4. International AIDS Society global scientific strategy: towards an HIV cure 2016

5. Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient and clinic staff perspectives on the implementation of a long-acting injectable antiretroviral therapy program in an urban safety-net health system;Implementation Science Communications;2024-08-29

2. “This Is Actually a Really Unique Moment in Time”: Navigating Long-Acting HIV Treatment and HIV Cure Research with Analytical Treatment Interruptions—A Qualitative Interview Study in the United States;AIDS Research and Human Retroviruses;2024-08-01

3. Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy;AIDS and Behavior;2024-07-01

4. LAI-ART Awareness, Willingness, Barriers and Facilitators among Black Sexual Minority Men Living with HIV in the US South;International Journal of Environmental Research and Public Health;2024-05-08

5. People with HIV at the end-of-life and their next-of-kin/loved ones are willing to participate in interventional HIV cure-related research;AIDS;2023-10-17